PROJECT EXAMPLE:

Cellink

COMPANY OVERVIEW

CELLINK

Cellink was founded to exploit the results of a EUREK/EUROSTAR project to develop a technology platform that would allow the biofabrication of 3D living human tissues in vitro that could be stable for weeks to months. It has grown rapidly in the past 3 years, from 24 employees to 119 as of May 2019.

Cellink's first product was a nanocellulose based bioink, together with a low-priced, entry-level bioprinter that sells for less than $5,000. The company has evolved its strategy from selling bioinks to offering a complete start-up package for beginners in bioprinting, to sale and marketing of systems consisting of several components; 3D bioprinter, stem cell bioinks, cell mixers and dosing equipment. Strategic alliances have been a key part of this process, with the company acquirers 2 parters, Dispendix and Cytena since November 2018.

Cellink is aiming for a NASDAQ listing in late 2019 or early 2020, which is reflected their expansive public relations and marketing messaging.

PRODUCTS

  • Cellink Bio X 3D Bioprinter
    Cellink's flagship product is a bench-top printer with 3 print heads.
    Accessories include HD Camera and UV Light cure modules.
    The base model sells for $5,000, and a range of bioinks that sell for $99 - $1,290 (average cost is $600)

  • Bioink Starter Kits & Accessories
    A wide range of bioinks are available that sell for $99 - $1,290 (average cost is $600).

  • INKREDIBLE Bioprinter
    Cellink's flagship product is a bench-top printer with 3 print heads.
    Accessories include HD Camera and UV Light cure modules.
    The base model sells for $5,000, and a range of bioinks that sell for $99 - $1,290 (average cost is $600)

  • Holograph X
    Holograph X employs high-resolution holographic stereolithography to bioprint extremely small structures.
    The proprietary multiphoton laser system prints biocompatible
    materials with up to 150,000 points of light per second to produce a user-generated structure, such as human capillaries and ultra-fine extracellular matrices.

  • CELLSIGHT X
    A live-cell imaging system
    Compact Design to fit inside conventional incubators
    Six slots for well plates and tissue flasks
    Track cell morphology moment-by-moment; 3 fluorescence channels (red, blue, green) to distinguish different cell structures, 5 megapixel camera.

MARKETING INITIATIVES

Click the icon to access or download the relevant document

Cellink Partnership Conference
New Orleans
December 10, 2020

Cellink BioX
Enclosed 3 Print Head System with HEPA filter & UV Light sterilisation. Interchangeable print heads, photocuring & HD camera options

Cellink CellcyteX
Live cell imaging system with space for 6 micro titre plates.
Small enough to fit inside an incubator

Bioverse.co User Community
Bioverse is a global 3D bioprinting community with Open Source CAD-models of human organs and tissue models, developed and maintained by Cellink AB


SALES STRUCTURE

My Image

Direct Offices:
Gothenburg, Sweden
Boston, MA; small office based in biocluster, Kendall Square
Kyoto; Small office located in Kyoto University's innovation hub.
Freiburg, Germany; Dispendix & Cytena offices.

International Distributors:

Canada: Spectra Research Corporation
USA:


FINANCIALS

Fundamentals

Financial Year 2018/2019

The company's Q3 2018/2019 results for the period to May 31 2019 show a 135% increase in revenue to SEK 39.7m (CHF $4.0m).

REVENUE * FY2017/2019 Revenue (9 months): SEK 39.7m (US$ 4.1m) * FY2018/2019 Revenue (12 months): SEK 45.3 (US$ 4.7m)

EBITDA * FY2017/2019 Profit (9 months): SEK 1.9m (US$ 190k ) * FY2018/2019 Profit (12 months): SEK 372k (US$ 39k )

NO. EMPLOYEES: * September 2018: 24 * September 2019: 74 * May 2019: 119


COMPANY BACKGROUND

Cellink is showing considerable public relations activity ahead of its planned IPO, scheduled for late 2019 ore early 2020. The articles below give an insight into the company, its founder and its strategy for growth.

Cellink, The Future of Medical Research

Erik Gatenholm, Co-Founder & CEO, CELLINK Published on November 16, 2016


Inside Cellink
'From startup to bio printing market leader, the bioinkredible rise of CELLINK'
Digital Trends
December 19, 2018

BBC News Article
'The firm that can 3D print human body parts'
November 15, 2017

Cellink raises $15.8m for Partner Acquisition
Cellink to acquire Dispendix, adding revenues of €3.5m
December 13, 2018

CELLINK is Bioprinting its Way into the Future
3DPrint.com Article
April 22, 2019


DOWNLOAD AREA

Click the Icon to download the respective document

Cellink acquires Cytena GmbH
€30.25m Acquisition
August 7, 2019

Interim Q3 Report 2018/2019
Revenue SEK 73.4m for first 9 months (+156% vs Prior Year)
EBITDA SEK 5.8m (7.9% margin)
Employees rose from 74 to 115
May 31, 2019

Annual Report 2017/2018
Revenue SEK45.3m (+245%) vs Prior Year
Employees rose from 24 to 74
August 31, 2018

Bringing 3D Bioprinting to the Market
Agile Marketing, Rapid Product Development and Strategic Alliances
(Erik Gatenholm, Cellink MBA Thesis)

October 26, 2019


+44 (0)771 898 3888
ian@mawhinney.com
VISIT ALLEVA.COM

© Ian Mawhinney 2025.
For projects visit Alleva Strategic Consulting